Article Listing - Takeda R&D meeting focuses on insomnia treatment Rozeram

MOMENTUM OF 1991 CONTINUES AT SB

27 April 1992

The momentum achieved by Anglo-American pharmaceutical company SmithKline Beecham in 1991 is continuing in 1992, the company's results for the...

PROCTER & GAMBLE PHARMACEUTICALS

27 April 1992

Norwich Eaton has now taken the name Procter and Gamble Pharmaceuticals. The change, according to company, is a sign of...

CANADA APPROVES INTERFERON ALFA

27 April 1992

The sale of two new products to treat patients infected with the hepatitis B virus has been approved in Canada....

ISRAELI INDUSTRY FACES PRICE PRESSURE

27 April 1992

In Israel, there have been demands that Hevrat Haovdim and the General Sick Fund, both...

US FDA SLAMMED FOR "GUERILLA WAR" TACTICS

27 April 1992

We are now witnessing the emergence of a period of fundamentalist regulation and enforcement at the US Food and Drug...

CPMP MEETING DECISIONS

27 April 1992

At a recent meeting of the European Community's Committee for Pro-prietary Medicinal Products, four multi-state and nine concertation (eight variations)...

POST-ELECTION OUTLOOK FOR UK HEALTH SECTOR

20 April 1992

The UK Health and Household sector looks set to continue its period of consolidation and to underperform the stock market...

GEHE SALES AND PROFITS grow IN 1991

20 April 1992

German Drug manufacturer Gehe made group sales in 1991 of just over 5 billion Deutschemarks ($3 billion), an increase of...

US Rx DRUG PRICES UP 4.1% IN 1ST QUARTER

20 April 1992

The US Bureau of Labor Statistics reports that prices of prescription drug products increased by an average of 4.1% in...

STOCK MARKET COMMENTARY: TOKYO

20 April 1992

TOKYO: finished the week with a 6.5% loss at 17,236 yen on Monday April 13, despite a sharp 1,252 point...

Showing 94161-94170 of 95329 articles